Despite our small numbers, we continue to be successful in attracting research funding largely because of a very wide collaborative network within medicine, pharmacy, epidemiology, health technology assessment, and the social sciences. Amongst our members, several million dollars worth of research grants and personnel funding are held. These come from a variety of sources, including the Canadian Institutes for Health Research (CIHR), Ontario Ministry of Health, Health Canada, local hospitals, and professional associations. Our graduate and undergraduate students continue to receive recognition awards for their high-quality research.
Our research topics focus on the benefits, harms, economics and perceptions of drug therapies. Studies are aimed at improving the quality of prescribing and medication utilization, including randomized management trials, observational studies using large health databases, systematic and scoping reviews, and qualitative studies. We lead projects examining the impact of electronic medical record-based decision support for medications, the impact of changes in drug policies on health and health care utilization, patient preferences regarding therapies, improving the quality of high-risk medication management for patients in transitions, cost-related medication nonadherence, and methods to assess individual benefit and harm. As well as scholarly papers and presentations, members of the division hold multiple copyrights and patents on research products, software, reports and guidances.
Our research benefits from direct practice and policy impact, given our many drug policy contacts in government, patient safety, and health technology assessment organizations.
November 9, 2020
November 9, 2020
September 18, 2020
Five McMaster University professors, all members of the Faculty of Health Sciences, are joining the Canadian Academy of Health Sciences (CAHS) as fellows.
September 15, 2020
It has been a year since the release of the McMaster Textbook of Internal Medicine, and already, it’s been accessed by tens of thousands of people around the world.
September 10, 2020
August 11, 2020
Working together, researchers at McMaster University and the University of Waterloo are searching for how the SARS-CoV-2 virus infects the lungs – and they’re challenging what has become an accepted truth about the virus.
August 5, 2020
Much has been made recently about the new antiviral drug remdesivir for COVID-19 patients, but a McMaster University-led guideline for physicians warns that it would only be used in the most serious cases, and more research is needed.
August 4, 2020
Researchers at McMaster University and the Royal Ontario Museum (ROM) have reported the discovery and diagnosis of an aggressive malignant bone cancer — an osteosarcoma — for the first time ever in a dinosaur.
July 23, 2020
A new McMaster University-based network will bring together researchers and patients to tackle sepsis — a leading cause of death in COVID-19.
July 14, 2020
July 13, 2020
June 25, 2020
McMaster University has garnered $20 million in new funding for 17 COVID-19 research projects from the Canadian Institutes of Health Research (CIHR) and their funding partners.
May 25, 2020
The evidence shows that cloth masks, particularly those with several layers of cotton cloth, block droplet and aerosol contamination of the environment, may reduce transmission of COVID-19.
April 14, 2020
Health sciences and engineering researchers at McMaster University have been racing to assist Woodbridge Foam Corporation in getting a new made-in-Canada mask designed, tested and certified, as supplies of existing medical masks become less certain.
November 15, 2019
New McMaster research has found a program that honours dying patients by fulfilling end of life wishes can be powerful, affordable and sustainable in many settings.
October 24, 2019 by Tina Depko, Health Sciences
The first edition of the McMaster Textbook of Internal Medicine is making its formal debut, fittingly, in time for the 50th anniversary celebrations of the Michael G. DeGroote School of Medicine this month.
August 6, 2019
A Hamilton-led international study of more than 3,000 patients could set the stage globally for how patients can safely use blood-thinning medications before and after surgery to mitigate risk of bleeding and stroke. The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) study was conducted across 23 clinical centres in Canada, United States and Europe.
July 29, 2019
It's the recovery period, not the operating room that is risky for patients undergoing non-cardiac surgery, according to a large international study led by McMaster University. Based on patients at 28 health centres in 13 countries, the results show less than one per cent of deaths of these patients occurred in the operating room, but 29 per cent of deaths occurred after discharge from hospital.
July 11, 2019
The 2019 Global Ranking of Academic Subjects has ranked McMaster’s clinical medicine and civil engineering programs 29th in the world. The clinical medicine is ranked second in Canada, and the civil engineering program is third in the country.
May 23, 2019
Deborah Cook, a renowned McMaster University professor, researcher and physician, has been named the recipient of the Canadian Institutes for Health Research (CIHR) Gold Leaf Prize for Impact.
March 14, 2019
McMaster University is receiving $8.45 million from the federal government to support 13 health research projects.
October 19, 2017 by Lori Dillon
The Good Bugs, Bad Bugs program, led by Canada Research Chair in Chemical Biology, Eric Brown, received nearly $6 million to allow researchers to generate a more thorough understanding of the ways in which microbes benefit us and sometimes cause disease.